Developer docs
API playgroundTry for free, no card

Search company profiles

LEVY Health

Full company profile

uuid00032ia

Namestring
LEVY Health
Legal namestring
LEVY Health
Websiteurl
levy.health
Company typeenum
Private
Founded yearint
2021
Descriptiontext

LEVY Health is a Berlin-based private femtech company founded in 2020/2021 that develops the LEVY Fertility Code, a CE-compliant clinical decision support software for diagnosing female fertility disorders. The platform encodes reproductive medical guidelines into a software workflow that analyzes patient inputs and produces personalized therapy recommendations, and is delivered through virtual care pathways that allow women and couples to access fertility diagnostics remotely.

The company's core technical asset is its guideline-encoded diagnostic engine, which is positioned as a CE-marked medical product in the EU. Beyond the diagnostic software, LEVY Health has expanded into direct-to-consumer virtual care delivery, offering remote fertility consultations and personalized recommendations through an online clinic model. Technology differentiators cited include diagnostic accuracy, configurability of therapy recommendations, and ease-of-use in virtual care delivery.

Commercially, LEVY Health operates a direct-to-consumer and product-led model, distributing through its own virtual care platform to women and couples seeking fertility care. Revenue streams are described as subscription/recurring for telehealth and remote diagnostic services, and potentially for software licensing to providers. The company has raised approximately $8M+ equivalent across seed (Atlantic Labs, 2022), an angel round (Springboard Health Angels, 2023), a Google for Startups program (2022), and a $4.5M round led by XYZ Venture Capital (October 2024) with Atlantic Labs and Possible Ventures participating. No revenue, customer counts, or pricing have been publicly disclosed.

Short descriptiontext

LEVY Health is a Berlin-based femtech company that develops the CE-compliant LEVY Fertility Code, a clinical decision support software for diagnosing female fertility disorders and recommending personalized therapies, delivered through virtual care pathways to women and couples.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBerlin, Germany
HQ citystring
Berlin
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
fertility diagnostic software, reproductive health software, clinical decision support, women's health platform, fertility telemedicine
Industry3 codes
1Fertility & Reproductive Endocrinology Telehealth (IVF/IUI, infertility evaluation)
CodeHLALAHAAPrimaryYes
2Women’s Health & Fertility Therapeutics (Digital)
CodeHLACANAKPrimaryNo
3Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening)
CodeHLAAALAJPrimaryNo
NAICS code1 code
  • Family Planning Centers621410
SIC code1 code
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Fertility Diagnostic Software
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Telehealth/Remote Diagnostic Services
TypeSubscription Recurring
Description

Online clinic providing remote fertility diagnosis services to women seeking to identify causes of infertility faster through virtual consultations

handelsblatt.com
2Medical Software Platform
TypeSubscription Recurring
Description

CE-compliant medical software product that analyzes fertility disorders and provides personalized therapy recommendations, potentially offered as a subscription or license to healthcare providers

eu-startups.com
Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2C
B2C
Offering typeSoftware
Software
Core offering1 text field

LEVY Health develops and delivers a CE-compliant medical software product (the LEVY Fertility Code) that diagnoses female fertility issues by integrating reproductive medical guidelines, complemented by a virtual care platform that delivers remote fertility diagnosis and personalized therapy recommendations directly to women and couples seeking to conceive.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Reduced diagnosis and treatment timelines for women seeking fertility care
+1 more record
Product overview1 text field

LEVY Health offers a single unified medical software product focused on fertility diagnosis. The core offering is a CE-compliant software platform that analyzes women's fertility disorders, integrates reproductive medical guidelines, and provides personalized therapy recommendations to assist women and couples seeking to conceive.

Product and service1 record
1LEVY Health Fertility Software (LEVY Fertility Code)
CategoryFertility Diagnostic Software
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

CE-marked digital therapeutic for contraception and fertility planning, marketed direct-to-consumer. Comparable regulatory profile (CE-compliant medical device) and overlap with women's reproductive health, though focused on cycle tracking rather than diagnostic decision support.

TypeDirect peer
Description

Virtual care platform for women's and family health, including fertility, pregnancy, and postpartum. Directly comparable to LEVY's DTC virtual fertility model, with a much larger global footprint and capital base.

TypeEmerging player
Description

Virtual fertility clinic offering financing, nurse navigation, and at-home diagnostics. Comparable virtual-first fertility care model, with an additional financing layer that LEVY does not currently offer.

4Apricity
TypeDirect peer
Description

UK/Europe-based virtual fertility clinic that combines remote consultations, at-home diagnostics, and personalized treatment guidance. Closest European peer to LEVY given its virtual-first fertility model and overlap on personalized therapy recommendations.

TypeRegional player
Description

Europe-based digital health platform offering telehealth and app-based care for chronic conditions including women's health. Comparable in regulatory profile (CE-marked) and European virtual-care distribution, but focused on nutritional and chronic-disease use cases rather than fertility.

TypeDirect peer
Description

US-based fertility and women's health clinic operator combining virtual and in-person care. Comparable in offering fertility diagnostics and personalized treatment plans, though with a hybrid clinic delivery model rather than purely virtual.

TypeDirect peer
Description

Global fertility benefits and virtual care platform serving employers and individuals. Comparable to LEVY's focus on improving access to fertility diagnostics, but operates primarily through employer-sponsored benefits rather than direct patient software.

TypeBroad incumbent
Description

US public fertility benefits and care management company combining benefit administration with clinical networks. Comparable end-customer use case (fertility diagnostics and treatment access) but a much broader, enterprise-led offering.

TypeEmerging player
Description

Virtual fertility counseling and digital support platform. Partial overlap with LEVY's personalized therapy recommendations, though more focused on emotional and educational support than clinical decision support.

TypeEmerging player
Description

Fertility prediction and personalized treatment-success analytics platform for clinics and patients. Comparable to LEVY's clinical decision support angle, but narrower in scope to IVF outcome prediction rather than end-to-end fertility diagnosis.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

LEVY Health

Fertility Diagnostic Softwarelevy.health

LEVY Health is a Berlin-based femtech company that develops the CE-compliant LEVY Fertility Code, a clinical decision support software for diagnosing female fertility disorders and recommending personalized therapies, delivered through virtual care pathways to women and couples.

What LEVY Health does

LEVY Health is a Berlin-based private femtech company founded in 2020/2021 that develops the LEVY Fertility Code, a CE-compliant clinical decision support software for diagnosing female fertility disorders. The platform encodes reproductive medical guidelines into a software workflow that analyzes patient inputs and produces personalized therapy recommendations, and is delivered through virtual care pathways that allow women and couples to access fertility diagnostics remotely.

The company's core technical asset is its guideline-encoded diagnostic engine, which is positioned as a CE-marked medical product in the EU. Beyond the diagnostic software, LEVY Health has expanded into direct-to-consumer virtual care delivery, offering remote fertility consultations and personalized recommendations through an online clinic model. Technology differentiators cited include diagnostic accuracy, configurability of therapy recommendations, and ease-of-use in virtual care delivery.

Commercially, LEVY Health operates a direct-to-consumer and product-led model, distributing through its own virtual care platform to women and couples seeking fertility care. Revenue streams are described as subscription/recurring for telehealth and remote diagnostic services, and potentially for software licensing to providers. The company has raised approximately $8M+ equivalent across seed (Atlantic Labs, 2022), an angel round (Springboard Health Angels, 2023), a Google for Startups program (2022), and a $4.5M round led by XYZ Venture Capital (October 2024) with Atlantic Labs and Possible Ventures participating. No revenue, customer counts, or pricing have been publicly disclosed.

LEVY Health firmographics

Firmographics
Name
LEVY Health
Legal name
LEVY Health
Website
https://levy.health
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
LEVY Health is a Berlin-based femtech company that develops the CE-compliant LEVY Fertility Code, a clinical decision support software for diagnosing female fertility disorders and recommending personalized therapies, delivered through virtual care pathways to women and couples.
Ownership category
akta.pro rank

LEVY Health industry classification

Industry
Product category
Fertility Diagnostic Software
NAICS
Family Planning Centers (621410)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro primary industry
Fertility & Reproductive Endocrinology Telehealth (IVF/IUI, infertility evaluation) (HLALAHAA)
akta.pro secondary industries
Women’s Health & Fertility Therapeutics (Digital) (HLACANAK), Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ)

Keywords

  • Fertility diagnostic software
  • Reproductive health software
  • Clinical decision support
  • Women's health platform
  • Fertility telemedicine

Where LEVY Health is headquartered

Location

Headquarters

HQ city
Berlin
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

LEVY Health business model

Business model
GTM type
B2C
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Telehealth/Remote Diagnostic Services: Online clinic providing remote fertility diagnosis services to women seeking to identify causes of infertility faster through virtual consultations
  2. Medical Software Platform: CE-compliant medical software product that analyzes fertility disorders and provides personalized therapy recommendations, potentially offered as a subscription or license to healthcare providers

Go-to-market motion2 records

Distribution channels1 record

LEVY Health product offering

Product offering

Core offering

LEVY Health develops and delivers a CE-compliant medical software product (the LEVY Fertility Code) that diagnoses female fertility issues by integrating reproductive medical guidelines, complemented by a virtual care platform that delivers remote fertility diagnosis and personalized therapy recommendations directly to women and couples seeking to conceive.

Product overview

LEVY Health offers a single unified medical software product focused on fertility diagnosis. The core offering is a CE-compliant software platform that analyzes women's fertility disorders, integrates reproductive medical guidelines, and provides personalized therapy recommendations to assist women and couples seeking to conceive.

Differentiator

Problem solved

Functional benefit

Products and services

  • LEVY Health Fertility Software (LEVY Fertility Code)

Quantifiable outcome

  • Reduced diagnosis and treatment timelines for women seeking fertility care
  • +1 more outcomes

Companies that use LEVY Health

Customer profile

Segments1 record

Ideal customer profiles1 record

LEVY Health technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

LEVY Health partnerships and signals

Strategic signal

Scale indicators2 records

Expansion highlights4 records

LEVY Health competitors and assessment

Company assessment

Emerging players

  • Natural Cycles: CE-marked digital therapeutic for contraception and fertility planning, marketed direct-to-consumer. Comparable regulatory profile (CE-compliant medical device) and overlap with women's reproductive health, though focused on cycle tracking rather than diagnostic decision support.
  • Future Family: Virtual fertility clinic offering financing, nurse navigation, and at-home diagnostics. Comparable virtual-first fertility care model, with an additional financing layer that LEVY does not currently offer.
  • Elanza Wellness: Virtual fertility counseling and digital support platform. Partial overlap with LEVY's personalized therapy recommendations, though more focused on emotional and educational support than clinical decision support.
  • Univfy: Fertility prediction and personalized treatment-success analytics platform for clinics and patients. Comparable to LEVY's clinical decision support angle, but narrower in scope to IVF outcome prediction rather than end-to-end fertility diagnosis.

Direct peers

  • Maven Clinic: Virtual care platform for women's and family health, including fertility, pregnancy, and postpartum. Directly comparable to LEVY's DTC virtual fertility model, with a much larger global footprint and capital base.
  • Apricity: UK/Europe-based virtual fertility clinic that combines remote consultations, at-home diagnostics, and personalized treatment guidance. Closest European peer to LEVY given its virtual-first fertility model and overlap on personalized therapy recommendations.
  • Kindbody: US-based fertility and women's health clinic operator combining virtual and in-person care. Comparable in offering fertility diagnostics and personalized treatment plans, though with a hybrid clinic delivery model rather than purely virtual.
  • Carrot Fertility: Global fertility benefits and virtual care platform serving employers and individuals. Comparable to LEVY's focus on improving access to fertility diagnostics, but operates primarily through employer-sponsored benefits rather than direct patient software.

Regional players

  • Oviva: Europe-based digital health platform offering telehealth and app-based care for chronic conditions including women's health. Comparable in regulatory profile (CE-marked) and European virtual-care distribution, but focused on nutritional and chronic-disease use cases rather than fertility.

Broad incumbents

  • Progyny: US public fertility benefits and care management company combining benefit administration with clinical networks. Comparable end-customer use case (fertility diagnostics and treatment access) but a much broader, enterprise-led offering.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

LEVY Health social profiles

Digital presence

LEVY Health compliance and trust

Trust signal

Compliance1 record

LEVY Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

LEVY Health leadership team

Management profile

Number of profiles

LEVY Health funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

LEVY Health M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LEVY Health

What does LEVY Health do?

LEVY Health develops and delivers a CE-compliant medical software product (the LEVY Fertility Code) that diagnoses female fertility issues by integrating reproductive medical guidelines, complemented by a virtual care platform that delivers remote fertility diagnosis and personalized therapy recommendations directly to women and couples seeking to conceive.

Is LEVY Health a public or private company?

LEVY Health is a private company. It is classified as venture growth investor backed and is currently operating.

When was LEVY Health founded?

LEVY Health was founded in 2021. It employs 11 to 50 people.

Where is LEVY Health based?

LEVY Health is headquartered in Berlin, Germany, in the Europe region.

How does LEVY Health make money?

Two revenue lines are on record. Telehealth/Remote Diagnostic Services are the primary driver. The others are medical Software Platform.

Who are LEVY Health's main competitors?

Emerging players on record are Natural Cycles, Future Family, Elanza Wellness and Univfy. Direct peers are Maven Clinic, Apricity, Kindbody and Carrot Fertility. Oviva is listed as a regional player. Progyny is listed as a broad incumbent.

Does LEVY Health have an API?

No public API is recorded for LEVY Health.

What industry is LEVY Health in?

LEVY Health's product category is Fertility Diagnostic Software. Its primary akta.pro industry code is HLALAHAA, Fertility & Reproductive Endocrinology Telehealth (IVF/IUI, infertility evaluation), with a secondary code of HLACANAK, Women’s Health & Fertility Therapeutics (Digital). Its NAICS code is 621410 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Pulse 2.0ONTO Health Acquires LEVY Health To Expand AI-Powered Fertility CareONTO Health announced the acquisition of LEVY Health, a clinical decision support software company specializing in precision diagnostics and patient intake for reproductive medicine. The acquisition integrates LEVY Health's technology into ONTO's platform, enabling physicians to identify endocrine disorders more efficiently, automate fertility workups, and improve diagnostic accuracy. The transaction supports ONTO Health's geographic expansion across the U.S. and into the Gulf Cooperation Council region, where demand for personalized fertility care continues to grow.PR NewswireONTO Health Accelerates U.S. and International Expansion with Acquisition of LEVY HealthONTO Health, a physician-led fertility and longevity provider, has acquired LEVY Health, a clinical decision support software company specializing in precision diagnostics and patient intake for reproductive medicine. The acquisition, completed following ONTO Health's $20 million Series A funding round, is intended to scale ONTO's tech-enabled infrastructure and support its expansion across the United States and into the Gulf Cooperation Council region. The strategic move targets the growing global fertility services market, projected to expand from $42.23 billion in 2023 to $70.27 billion by 2030.VenturecapitalONTO Health Acquires LEVY Health To Expand Fertility and Longevity CareONTO Health acquired LEVY Health to scale its tech-enabled infrastructure for reproductive medicine, targeting the growing global demand for personalized fertility care. The global fertility services market is projected to reach $70.27 billion by 2030.HomepageONTO Health Acquires LEVY Health to Scale Fertility Care Infrastructure Across the U.S. and GCCONTO Health acquired LEVY Health, a clinical decision support platform for reproductive medicine, to scale fertility care infrastructure. The deal follows ONTO's $20 million Series A and aims to integrate low-complexity fertility care into existing clinic workflows. The acquisition supports expansion across the U.S. and Gulf Cooperation Council region.TechRoundPCOS And AI: Can Algorithms Finally Help Women Get Diagnosed Faster?AI and machine learning can diagnose PCOS with 80-90% accuracy, but clinical deployment faces data bias and reliability issues. The FemTech market grew 55% in 2024, with PCOS startups raising $72 million in March 2026. Investors now prioritize clinical validation and real-world integration over demo-day metrics.PR NewswireLEVY Health Partners with IVF Academy USA to Support OB-GYN Training in Fertility MedicineLEVY Health, a medical software company specializing in precision diagnostics and patient intake for reproductive medicine, announced a collaboration with Texas-based IVF Academy USA to integrate its clinical decision support software into the Academy's OB-GYN training programs. The software enables evidence-based clinical decision-making, analyzing up to 120 biomarkers across more than two million diagnostic scenarios and integrating data from major US laboratories. The partnership aims to address the growing demand for fertility care by preparing OB-GYNs transitioning into fertility practice with scalable, technology-enabled training tools.PR NewswireLEVY Health Partners with Everie Known Donation Program to Transform the Egg Donation ProcessLEVY Health has announced a partnership with Everie, an egg bank, to integrate advanced screening technology into the egg donation process. The collaboration leverages LEVY Health's algorithms to provide personalized reproductive health assessments for potential donors, identify health risks such as hormonal disorders or low ovarian reserve, and reduce the donation timeline from initial contact to just 2–3 months. Both companies emphasize combining cost efficiency with ethical standards, with features including comprehensive ovarian reserve testing and increased inclusivity in donor eligibility.Pulse 2.0LEVY Health: Reproductive Technology Company Raises $4.5 MillionLEVY Health raised $4.5 million led by XYZ Venture Capital to integrate its virtual care pathways with electronic medical record software. The company's software reduces treatment timelines from 145 days to 45 and supports 152 diagnoses. It is now developing applications for fertility clinics, benefit providers, laboratories, and biopharma companies.FinSMEsLEVY Health Raises $4.5M in FundingLEVY Health, a San Francisco-based reproductive health technology company, raised $4.5M in funding led by XYZ Venture Capital with participation from Atlantic Labs and Possible Ventures. The company will use the funds to integrate its virtual care pathways with electronic medical record software and accelerate growth across women's health and reproductive care.Venture Capital Access OnlineLEVY Health Secures $4.5 Million in Funding to Expedite Diagnosis and Care in Reproductive HealthLEVY Health has secured $4.5 million in funding led by XYZ Venture Capital to expand its reproductive health technology platform and integrate virtual care pathways with electronic medical records. The company aims to address the shortage of specialists by using clinical decision support software that reduces diagnosis and treatment timelines from years to weeks. This capital will fuel growth across women's health verticals, including fertility clinics, benefit providers, and biopharma companies.